Gaingels
Overview
Gaingels is a venture capital investment firm that focuses on investing in companies with diverse and underrepresented leadership, including LGBTQIA+ individuals, and those promoting progressive social values. It is a venture investment syndicate in support of the LGBTQIA+ community and its allies in the venture capital space. Gaingels also supports its companies with a diverse talent and capital pipeline and provides an internal diverse board member recruitment advisory to help bring more diversity and representation within private boards.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Superluminal Medicines | Sep 2026 | Series B | Co-investor |
| Molten Salt Solutions | Aug 2026 | Seed | Co-investor |
| Concordare Trials | Aug 2026 | Seed | Co-investor |
| Standard Metrics | Aug 2026 | Series B | Co-investor |
| Thea Energy | Aug 2026 | Series B Extension | Co-investor |
Key People
David Beatty
Founder & Managing Member
Paul Grossinger
Founder
Jennifer Jeronimo
Chief Executive Officer
Peter Steinberg
General Partner
Lorenzo Thione
Managing Director
Ashley L. Flucas
Venture Partner
Emilie Poteat
Venture Partner
Jason Ve
Venture Partner
Kolb Raymond
Venture Partner
Nancy Fechnay
Venture Partner
Patrick Driscoll
Venture Partner
Heath Naquin
Principal
Todd Havill
Principal
Alan Masarsky
Investor
Angelo Liao
Investor
Annette Fay
Member Investor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
